Fundamental Scientific Research of the State Academies of Sciences for 2014–2021 (grant no. 0710-2019-0044)

Link to this page

Fundamental Scientific Research of the State Academies of Sciences for 2014–2021 (grant no. 0710-2019-0044)

Authors

Publications

Experimental and In Silico Evaluation of New Heteroaryl Benzothiazole Derivatives as Antimicrobial Agents

Zubenko, Alexander; Kartsev, Victor; Petrou, Anthi; Geronikaki, Athina; Ivanov, Marija; Glamočlija, Jasmina; Soković, Marina; Divaeva, Lyudmila; Morkovnik, Anatolii; Klimenko, Alexander

(Basel: MDPI, 2022)

TY  - JOUR
AU  - Zubenko, Alexander
AU  - Kartsev, Victor
AU  - Petrou, Anthi
AU  - Geronikaki, Athina
AU  - Ivanov, Marija
AU  - Glamočlija, Jasmina
AU  - Soković, Marina
AU  - Divaeva, Lyudmila
AU  - Morkovnik, Anatolii
AU  - Klimenko, Alexander
PY  - 2022
UR  - https://www.mdpi.com/2079-6382/11/11/1654
UR  - http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC9686863
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/5399
AB  - In this manuscript, we describe the design, preparation, and studies of antimicrobial activity of a series of novel heteroarylated benzothiazoles. A molecular hybridization approach was used for the designing compounds. The in vitro evaluation exposed that these compounds showed moderate antibacterial activity. Compound 2j was found to be the most potent (MIC/MBC at 0.23-0.94 mg/mL and 0.47-1.88 mg/mL) On the other hand, compounds showed good antifungal activity (MIC/MFC at 0.06-0.47 and 0.11-0.94 mg/mL respectively) with 2d being the most active one. The docking studies revealed that inhibition of E. coli MurB and 14-lanosterol demethylase probably represent the mechanism of antibacterial and antifungal activities.
PB  - Basel: MDPI
T2  - Antibiotics
T1  - Experimental and In Silico Evaluation of New Heteroaryl Benzothiazole Derivatives as Antimicrobial Agents
IS  - 11
VL  - 11
DO  - 10.3390/antibiotics11111654
SP  - 1654
ER  - 
@article{
author = "Zubenko, Alexander and Kartsev, Victor and Petrou, Anthi and Geronikaki, Athina and Ivanov, Marija and Glamočlija, Jasmina and Soković, Marina and Divaeva, Lyudmila and Morkovnik, Anatolii and Klimenko, Alexander",
year = "2022",
abstract = "In this manuscript, we describe the design, preparation, and studies of antimicrobial activity of a series of novel heteroarylated benzothiazoles. A molecular hybridization approach was used for the designing compounds. The in vitro evaluation exposed that these compounds showed moderate antibacterial activity. Compound 2j was found to be the most potent (MIC/MBC at 0.23-0.94 mg/mL and 0.47-1.88 mg/mL) On the other hand, compounds showed good antifungal activity (MIC/MFC at 0.06-0.47 and 0.11-0.94 mg/mL respectively) with 2d being the most active one. The docking studies revealed that inhibition of E. coli MurB and 14-lanosterol demethylase probably represent the mechanism of antibacterial and antifungal activities.",
publisher = "Basel: MDPI",
journal = "Antibiotics",
title = "Experimental and In Silico Evaluation of New Heteroaryl Benzothiazole Derivatives as Antimicrobial Agents",
number = "11",
volume = "11",
doi = "10.3390/antibiotics11111654",
pages = "1654"
}
Zubenko, A., Kartsev, V., Petrou, A., Geronikaki, A., Ivanov, M., Glamočlija, J., Soković, M., Divaeva, L., Morkovnik, A.,& Klimenko, A.. (2022). Experimental and In Silico Evaluation of New Heteroaryl Benzothiazole Derivatives as Antimicrobial Agents. in Antibiotics
Basel: MDPI., 11(11), 1654.
https://doi.org/10.3390/antibiotics11111654
Zubenko A, Kartsev V, Petrou A, Geronikaki A, Ivanov M, Glamočlija J, Soković M, Divaeva L, Morkovnik A, Klimenko A. Experimental and In Silico Evaluation of New Heteroaryl Benzothiazole Derivatives as Antimicrobial Agents. in Antibiotics. 2022;11(11):1654.
doi:10.3390/antibiotics11111654 .
Zubenko, Alexander, Kartsev, Victor, Petrou, Anthi, Geronikaki, Athina, Ivanov, Marija, Glamočlija, Jasmina, Soković, Marina, Divaeva, Lyudmila, Morkovnik, Anatolii, Klimenko, Alexander, "Experimental and In Silico Evaluation of New Heteroaryl Benzothiazole Derivatives as Antimicrobial Agents" in Antibiotics, 11, no. 11 (2022):1654,
https://doi.org/10.3390/antibiotics11111654 . .
3
3